cyclohexanols - CISMeF

Preferred Label : cyclohexanols;

MeSH definition : Monohydroxy derivatives of cyclohexanes that contain the general formula R-C6H11O. They have a camphorlike odor and are used in making soaps, insecticides, germicides, dry cleaning, and plasticizers.;

MeSH hyponym : cyclohexanol;

MeSH Related Number : cyclohexanol; 8E7S519M3P;

Related CAS MeSH : 8E7S519M3P (Cyclohexanol);

MeSH annotation : do not confuse with CYCLOHEXANONES;

Wikipedia link : https://en.wikipedia.org/wiki/Cyclohexanol;

Is substance : O;

Details

Origin ID

D003511;

UMLS CUI

C0010570;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Cyclohexanol [ICD-11 Extension code]
- cyclohexanol [SNOMED Notion]
Ne pas confondre avec
- cyclohexanones [MeSH Descriptor]
Record concept(s)
- cyclohexanol [MeSH concept]
- cyclohexanols [MeSH concept]
Related MeSH Supplementary Concept(s)
- (1S)-3,4-epoxy-2,2,5,5-tetramethylcyclohexanol [MeSH Supplementary Concept]
- (1S*,2S*,4S*,5S*)-cyclohexane-1,2,4,5-tetrol monohydrate [MeSH Supplementary Concept]
- 1,2,3-cyclohexanetriol-1-phosphate [MeSH Supplementary Concept]
- 1,2-cyclohexanediol [MeSH Supplementary Concept]
- 1,3,4-trihydroxycyclohex-5-en-1-carboxylic acid [MeSH Supplementary Concept]
- 1,3,5-triamino-2,4,6-trihydroxycyclohexane [MeSH Supplementary Concept]
- 1,4-cyclohexanediol [MeSH Supplementary Concept]
- 1-(1-dimethylaminomethyl-5-methoxybenzocyclobutan-1-yl)cyclohexanol [MeSH Supplementary Concept]
- 1-(2''-hydroxycyclohexyl)-3'-aminopropyl-4-(3'-aminopropyl)piperazine [MeSH Supplementary Concept]
- 1-(4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl)-3-methylcyclohexanol [MeSH Supplementary Concept]
- 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-yl)cyclohexanol [MeSH Supplementary Concept]
- 1-isopropyl-4-methylbicyclo(3.1.0)hex-3-en-2-ol [MeSH Supplementary Concept]
- 1-phenyl-1,2-cyclohexanediol [MeSH Supplementary Concept]
- 1-phosphoryloxy-2,4-dihydroxycyclohexane [MeSH Supplementary Concept]
- 2,3,4,5,6-pentachlorocyclohexanol [MeSH Supplementary Concept]
- 2,3,4,5-tetrahydroxycyclohexanemethanol [MeSH Supplementary Concept]
- 2,3,4-trihydroxycyclohexanone [MeSH Supplementary Concept]
- 2,3,5,6-tetrachlorocyclohexane-1,4-diol [MeSH Supplementary Concept]
- 2,5-dichloro-2,5-cyclohexadiene-1,4-diol [MeSH Supplementary Concept]
- 2,6-dimethylcyclohexanol [MeSH Supplementary Concept]
- 2-(1-hydroxyprop-2-yl)-5-methylcyclohexanol [MeSH Supplementary Concept]
- 2-(2,3-anthracenedicarboximido)cyclohexanol [MeSH Supplementary Concept]
- 2-(3-azibutylthio)-5,6-epoxy-3-cyclohexen-1-ol [MeSH Supplementary Concept]
- 2-(4-(4-iodophenyl) piperidino)cyclohexanol [MeSH Supplementary Concept]
- 2-(methyl(3-phenylpropyl)amino)cyclohexanol [MeSH Supplementary Concept]
- 2-(methyl(phenethyl)amino)cyclohexanol [MeSH Supplementary Concept]
- 2-amino-5-(4-chlorophenylethynyl)-4-(4-hydroxycyclohexylamino)pyrimidine [MeSH Supplementary Concept]
- 2-aminocyclohexanol [MeSH Supplementary Concept]
- 2-phenyl-1-cyclohexanol [MeSH Supplementary Concept]
- 26-hydroxy-22-methylcycloirid-16-enal [MeSH Supplementary Concept]
- 3,3,5-trimethylcyclohexanol [MeSH Supplementary Concept]
- 3,4-diaminocyclohexanol [MeSH Supplementary Concept]
- 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol [MeSH Supplementary Concept]
- 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol [MeSH Supplementary Concept]
- 3-aminocyclohexane-1,2-diol [MeSH Supplementary Concept]
- 3-chloro-4-(2-hydroxypropan-2-yl)-1-methylcyclohexane-1,2-diol [MeSH Supplementary Concept]
- 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol [MeSH Supplementary Concept]
- 3-methylcyclohexanol [MeSH Supplementary Concept]
- 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenyl 3-nitrophenyl ether [MeSH Supplementary Concept]
- 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenyl 4-methoxybenzoate hydrochloride [MeSH Supplementary Concept]
- 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenyl 4-methylbenzoate [MeSH Supplementary Concept]
- 4-(2-ethoxy-5-(4-ethylbenzyl)phenyl)-6-(hydroxymethyl)cyclohexane-1,2,3-triol [MeSH Supplementary Concept]
- 4-(2-hydroxycyclohexyl)-2-(trifluoromethyl)benzonitrile [MeSH Supplementary Concept]
- 4-(2-hydroxypropan-2-yl)-1-methylcyclohexane-1,2-diol [MeSH Supplementary Concept]
- 4-(3,4-dichlorophenyl)-4-((dimethylamino)methyl)-1-methylcyclohexanol [MeSH Supplementary Concept]
- 4-(3-hydroxybutyl)-3,3,5-trimethylcyclohex-4-ene-1,2-diol [MeSH Supplementary Concept]
- 4-(4-(aminomethyl)-7a-methyl-1-methylideneoctahydro-1H-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol [MeSH Supplementary Concept]
- 4-(4-bromophenyl)-4-(dimethylamino)-1-phenethylcyclohexanol [MeSH Supplementary Concept]
- 4-(9-(tetrahydrofuran-3-yl))-8-(2,4,6-trifluorophenylamino)-9H-purin-2-ylaminocyclohexan-1-ol [MeSH Supplementary Concept]
- 4-(9-(tetrahydrofuran-3-yl)-8-(2,4,6-trifluorophenylamino)-9H-purin-2-ylamino)cyclohexanol [MeSH Supplementary Concept]
- 4-acetamido-5-amino-1,2,3-cyclohexanetriol [MeSH Supplementary Concept]
- 4-acetamido-5-amino-3-O-(glucopyranosyluronic acid)-1,2,3-cyclohexanetriol [MeSH Supplementary Concept]
- 4-aminocyclohexanol [MeSH Supplementary Concept]
- 4-hydroxy-2-cyclohexenone [MeSH Supplementary Concept]
- 4-isopropylcyclohexanol [MeSH Supplementary Concept]
- 4-methylcyclohexanol [MeSH Supplementary Concept]
- 4-tert-butylcyclohexanol [MeSH Supplementary Concept]
- 4205CERM [MeSH Supplementary Concept]
- 5,6-dihydroxycyclohexa-1,3-diene [MeSH Supplementary Concept]
- 5-carbafructofuranose 6-phosphate [MeSH Supplementary Concept]
- 6-aminocyclohex-4-ene-1,2,3-triol [MeSH Supplementary Concept]
- 6-hydroxy-4-(1-hydroxy-1-methylethyl)-1-cyclohexene-1-ethanol [MeSH Supplementary Concept]
- A80915C [MeSH Supplementary Concept]
- AO 128 [MeSH Supplementary Concept]
- BP1.4160 [MeSH Supplementary Concept]
- CP 47497 [MeSH Supplementary Concept]
- EP 185 [MeSH Supplementary Concept]
- KD 16U1 [MeSH Supplementary Concept]
- N,O-didesmethylvenlafaxine [MeSH Supplementary Concept]
- N-(2-hydroxycyclohexyl)valiolamine [MeSH Supplementary Concept]
- N-(4-hydroxycyclohex-2-en-1-yl)quinoline-2-carboxamide [MeSH Supplementary Concept]
- N-desmethylvenlafaxine [MeSH Supplementary Concept]
- O-ethyl-3-butylcyclohexanol [MeSH Supplementary Concept]
- PH 163 [MeSH Supplementary Concept]
- UNC2250 [MeSH Supplementary Concept]
- UNC2881 [MeSH Supplementary Concept]
- WY 45,818 [MeSH Supplementary Concept]
- ZINC22066495 [MeSH Supplementary Concept]
- apiosporamide [MeSH Supplementary Concept]
- asterina-330 [MeSH Supplementary Concept]
- axomadol [MeSH Supplementary Concept]
- bisacurone [MeSH Supplementary Concept]
- boscialin [MeSH Supplementary Concept]
- canventol [MeSH Supplementary Concept]
- carbaglucosamine [MeSH Supplementary Concept]
- carbagulopyranose [MeSH Supplementary Concept]
- cis-3-methoxycyclohexanol [MeSH Supplementary Concept]
- citrantifidiol [MeSH Supplementary Concept]
- conduramine A-1 [MeSH Supplementary Concept]
- conduramine B-2 [MeSH Supplementary Concept]
- conduramine E [MeSH Supplementary Concept]
- conduritol B [MeSH Supplementary Concept]
- coniferan [MeSH Supplementary Concept]
- cyclohex-2-ene-1,4-diol [MeSH Supplementary Concept]
- cyclohexane-1,3-diol [MeSH Supplementary Concept]
- cyclohexyl cysteinate [MeSH Supplementary Concept]
- cyclophellitol [MeSH Supplementary Concept]
- dembrexine [MeSH Supplementary Concept]
- dibenzylamino-1-methylcyclohexanol [MeSH Supplementary Concept]
- dibenzylamino-1-trifluoromethylcyclohexanol [MeSH Supplementary Concept]
- dicyclohexanol propane [MeSH Supplementary Concept]
- ent-conduramine F-2 [MeSH Supplementary Concept]
- euhalothece-362 [MeSH Supplementary Concept]
- gadusol [MeSH Supplementary Concept]
- grasshopper ketone [MeSH Supplementary Concept]
- immunophilin ligand 506BD [MeSH Supplementary Concept]
- isoepoxydon [MeSH Supplementary Concept]
- lachnumol A [MeSH Supplementary Concept]
- linalool oxide [MeSH Supplementary Concept]
- lomibuvir [MeSH Supplementary Concept]
- monastrol antagonizing compound 1 [MeSH Supplementary Concept]
- mycosporine hydroxyglutamicol [MeSH Supplementary Concept]
- mycosporine-2-glycine [MeSH Supplementary Concept]
- mycosporine-glutamicol-glucoside [MeSH Supplementary Concept]
- narivent [MeSH Supplementary Concept]
- palitantin [MeSH Supplementary Concept]
- palythine [MeSH Supplementary Concept]
- phomentrioloxin [MeSH Supplementary Concept]
- phomentrioloxin B [MeSH Supplementary Concept]
- phomentrioloxin C [MeSH Supplementary Concept]
- ro 15-8081 [MeSH Supplementary Concept]
- speciosin B [MeSH Supplementary Concept]
- streptol [MeSH Supplementary Concept]
- trans-1-acetyl-4-phenylcyclohexanol [MeSH Supplementary Concept]
- trans-2-morpholinocyclohexanol [MeSH Supplementary Concept]
- trans-4-(p-bromophenyl)-4-(dimethylamino)-1-(2-thiophen-2-yl-ethyl)-cyclohexanol [MeSH Supplementary Concept]
- uvamalol A [MeSH Supplementary Concept]
- valibose [MeSH Supplementary Concept]
- valiolol [MeSH Supplementary Concept]
- vomifoliol 9-O-arabinofuranosyl-(1-6)-glucopyranoside [MeSH Supplementary Concept]
- wy 45881 [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
Validated automatic mappings to BTNT
- Cyclohexanol [LOINC component]
- Cyclohexanol (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients